• Home
  • About Us
    • About Us
    • Subscribe
    • Privacy Policy
  • Advertise
    • Advertise On IP Watch
    • Editorial Calendar
  • Videos
  • Links
  • Help

Intellectual Property Watch

Original news and analysis on international IP policy

  • Copyright
  • Patents
  • Trademarks
  • Opinions
  • People News
  • Venues
    • Bilateral/Regional Negotiations
    • ITU/ICANN
    • United Nations – other
    • WHO
    • WIPO
    • WTO/TRIPS
    • Africa
    • Asia/Pacific
    • Europe
    • Latin America/Caribbean
    • North America
  • Themes
    • Access to Knowledge/ Open Innovation & Science
    • Food Security/ Agriculture/ Genetic Resources
    • Finance
    • Health & IP
    • Human Rights
    • Internet Governance/ Digital Economy/ Cyberspace
    • Lobbying
    • Technical Cooperation/ Technology Transfer
  • Health Policy Watch

Anti-Counterfeit Medicines Convention Foreseen In 2010

14/10/2009 by Intellectual Property Watch 1 Comment

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Governments, international organisations and non-governmental organisations have been called on by a meeting of international leaders to “take full measure of the public health and public safety stakes linked to the scourge of counterfeit medication and to decide at the national level of the appropriate measures to be applied.” Stakeholders were invited to an as-yet unspecified global conference in Geneva in 2010 to establish the basis of an international convention against counterfeit medicines. The call did not explicitly define the term “counterfeit” but specified that quality generic drugs continue to be made widely available. There has been confusion about the definition of counterfeit drugs. (IPW, Public Health, 4 October 2009)

United Nations Secretary-General Ban Ki-Moon called for a collective action to fight fake medicines during the 12 October “Call of Cotonou” meeting in Benin, on the trafficking of counterfeit medicines, according to a UN press release.
The initiative was organised by the former French President Jacques Chirac’s foundation. The so-called Call of Cotonou states that, according to the WHO, in developing countries, one out of every four medicines is counterfeit.

The call is part of an international mobilisation campaign launched by the Fondation Chirac. One goal of the campaign is to create a new legal framework involving the health industry, law enforcement and customs officials. Campaign partners are largely industry-oriented.

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to email this to a friend (Opens in new window)
  • Click to print (Opens in new window)

Related

Creative Commons License"Anti-Counterfeit Medicines Convention Foreseen In 2010" by Intellectual Property Watch is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Filed Under: IP-Watch Briefs, English

Comments

  1. Sivong SENGALOUNDETH says

    02/02/2012 at 3:30 am

    I deeply apprecite the initiative to combat against counterfeit medicines. The National Medicines Regulatory Authority of thw whole world should closely working together, thinking and planning together to find the best ways to take in action for the common world goal to eradicate the counterfeit and sub-standard medines.

    Reply

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

  • Email
  • Facebook
  • LinkedIn
  • RSS
  • Twitter
  • Vimeo
My Tweets

IPW News Briefs

Saudis Seek Alternative Energy Partners Through WIPO Green Program

Chinese IP Officials Complete Study Of UK, European IP Law

Perspectives on the US

In US, No Remedies For Growing IP Infringements

US IP Law – Big Developments On The Horizon In 2019

More perspectives on the US...

Supported Series: Civil Society And TRIPS Flexibilities

Civil Society And TRIPS Flexibilities Series – Translations Now Available

The Myth Of IP Incentives For All Nations – Q&A With Carlos Correa

Read the TRIPS flexibilities series...

Paid Content

Interview With Peter Vanderheyden, CEO Of Article One Partners

More paid content...

IP Delegates in Geneva

  • IP Delegates in Geneva
  • Guide to Geneva-based Public Health and IP Organisations

All Story Categories

Other Languages

  • Français
  • Español
  • 中文
  • اللغة العربية

Archives

  • Archives
  • Monthly Reporter

Staff Access

  • Writers

Sign up for free news alerts

This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy

Copyright © 2025 · Global Policy Reporting

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.